Microbiome Technology Articles & Analysis
15 news found
KINS will be the first company to use the Collaboration Lab since JSR BiRD opened. KINS is a health technology company that supports the care of microbiome, which is responsible for health and vitality throughout the body, and accelerates research while building and analyzing databases of microbiome samples from skin, scalp, intestines, and ...
(California, USA) to work on microbial fermentation and novel prebiotics to modulate the human gut microbiome. Microviable expertise on gut microbiome research will enable to conveniently process microbiota samples for fermentation applications that coupled with BCD Bioscience advance prebiotics platform will open new avenues into human health and nutrition. ...
This comprehensive list featured an outstanding publication from our co-founders and SAB members on Precision modification of the human gut microbiota based on selective targeting of surface-associated proteins.Importantly, it is one of the few manuscripts listed that is related to microbiome, where most of the others are covid-19 or CRISPR-related. We are thrilled to have ...
Microbiome precision medicine company Bio-Me today announced that Dr. Warren Flood has become CEO following his successful period as COO. ...
ByBio-Me
CD Genomics is a leading services company committed to providing global customers with the most comprehensive analytic services, including a broad range of microbial genomic solutions to support research and development. The company announced microbiome profiling services, alongside bioinformatic analysis technology to help researchers understand the significance ...
Isaksen will first be presenting how we support companies in their development of microbiome modulating drugs with our PMP™ technology for targeted microbiome analysis. ...
ByBio-Me
He is a Senior Advisor at NeoMed Management, a European-based venture capital fund focused on healthcare and medical technology, Chair of Sonitor Technologies AS, a board member of Respinor AS and Cardiaccs, and a member of Excite International’s Executive Board. ...
ByBio-Me
These technologies are effective for single microbes, complex microbial consortia and whole microbiome products, and are integrated with a computational AI platform, which enables the design of unique microbial consortia and whole microbiome profiles. The technologies are highly potent and suitable for patients with ...
Intus Biosciences, a microbiome research company that develops tools for characterizing microbiome populations down to the strain level, was recently awarded a new patent by the United States Patent and Trademark Office. The patent, U.S. Patent 10,894,990, was awarded January 19, 2021, for a “High Throughput Method For Identification and Sequencing of Unknown Microbial and Eukaryotic ...
” In addition to SeylanMED’s topical AKT inhibitor gel for the treatment of SKs, DermBiont plans to initiate least four other phase 2b clinical trials in 2021 with live bacterial therapeutics discovered internally from its microbiome platform technology. “We are rapidly advancing proprietary, first-in-class, targeted topical drug candidates ...
Microbiotica, a leading player in microbiome-based therapeutics and biomarkers, has been named Business Weekly Young Company of the Year 2020. ...
In a recent paper in Gut Microbes the founders of MedBiome reported the effects of berberine (BBR) and 16 structural analogs on seven individual gut microbiomes using our RapidAIM technology. This article clearly illustrates that the RapidAIM technology can distinguish the effects of structurally similar compounds on individual ...
MedBiome’s founders reported in Microbiome the development of the RapidAIM platform to screen compounds against individual microbiomes in vitro. They tested 43 compounds (including 4 antibiotics) against 5 individual microbiomes using the RapidAIM technology. The RapidAIM workflow provides insights into ...
MedBiome is pleased to announce that it has exclusively licensed the RapidAIM technology from the University of Ottawa. RapidAIM is a revolutionary assay to rapidly determine the effects of compounds on individual human living microbiomes. ...
Affordable next-generation sequencing technologies have transformed microbiome research, resulting in huge volumes of microbiome-generated data that require advanced informatics. ...